Section Arrow
NPCE.NASDAQ
- Neuropace
Quotes are at least 15-min delayed:2024/04/24 01:40 EDT
Last
 14.02
+0.02 (+0.14%)
Day High 
14.505 
Prev. Close
14 
1-M High
15.7747 
Volume 
152.88K 
Bid
13.98
Ask
14.04
Day Low
13.6 
Open
14.15 
1-M Low
12.1 
Market Cap 
396.82M 
Currency USD 
P/E -- 
%Yield
10-SMA 14.09 
20-SMA 13.77 
50-SMA 14.5 
52-W High 18.15 
52-W Low 3.795 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.27/--
Enterprise Value
467.59M
Balance Sheet
Book Value Per Share
0.73
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
65.42M
Operating Revenue Per Share
2.12
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SINTSiNtx Technologies0.036-0.002-5.26%-- 
PACBPacific Biosciences of California1.47-0.09-5.77%-- 
BSXBoston Scientific Corp68.99+0.97+1.43%63.57PE
NUWENuwellis0.3034-0.0306-9.16%-- 
CATXPerspective Therapeutics1.7+0.17+11.11%-- 
Quotes are at least 15-min delayed:2024/04/24 01:40 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.